journal article·2008-04

Preparation of stabilized lidocaine particles by a combination of supercritical CO2 technique and particle surface control

Jintao Huang, Takashi Moriyoshi

Journal of Materials Science· Volume 43· Issue 7
Publisher page

Abstract

Lidocaine particles were prepared by the rapid expansion of the supercritical fluids into aqueous solution (RESAS). About 150–300 nm lidocaine particles could be temporarily observed when collected in water at concentration of 10 mg/cc, but the particles developed into 50 μm needle crystals just 30 min later. To prevent the fast aggregation of the particles as well as further crystal growth, modifications on particle surfaces by adding surfactants and introduction of electrostatic repulsion between particles were conducted. When a surfactant (sucrose stearic acid ester S-1570) was added to the collecting aqueous solution, the particle growth was alleviated and no large needle crystals were formed. However, the long-term stability needs to be improved because the lidocaine particles tend to grow from submicron to a few microns in a few days even stored in the 1% S-1570 solution. Electrostatic repulsion between particles is found effective to stabilize the submicron particles during the storage. When the pH value of the aqueous solution with 1% S-1570 was adjusted to 8.5 by adding KOH, the lidocaine particles suspending in this solution showed good stability that the particle size was able to be controlled in submicron level in 3 months.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Phase Equilibria and Thermodynamics · Innovative Microfluidic and Catalytic Techniques Innovation · Microfluidic and Capillary Electrophoresis Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (11)

Show source-provided references
1. Sane A et al (2003) Chem Commun 21:272010.1039/b306967b ↗
2. Debenedetti PG (1994) In: Supercritical fluids: fundamentals for application. Kluwer Academic Publications, pp 719–72910.1007/978-94-015-8295-7_32 ↗
3. Helfgen B, Turk M, Schaber K (2003) J Supercrit Fluid 26:22510.1016/S0896-8446(02)00159-6 ↗
4. Young TJ et al (2000) Biotechnol Prog 16:40210.1021/bp000032q ↗
5. Sun YP et al (2001) Langmuir 17:570710.1021/la0103057 ↗
6. Türk M, Lietzow R (2004) AAPS Pharma Sci Tech 5(4) Article 5610.1208/pt050456 ↗
7. Perrut M et al (2005) J Supercrit Fluid 288:3
8. Sane A, Thies MC (2007) J Supercrit Fluids 40:13410.1016/j.supflu.2006.04.003 ↗
9. Frank SG, Ye C (2000) In: Eckert C, Teja A (eds) Proceedings (CD-ROM) of the fifth international symposium on supercritical fluids (ISSF2000), Atlanda, GA, April 2000
10. Huang J, Moriyoshi T (2006) J Supercrit Fluid 37:29210.1016/j.supflu.2005.11.024 ↗
11. Meziani MJ et al (2004) Angew Chem Int Ed 43:70410.1002/anie.200352834 ↗